Eligibility requirements for filing a Wegovy blood clot lawsuit: Received Wegovy treatments Received a diagnosis of blood clot-related conditions, such as deep vein thrombosis (DVT) or pulmonary embolism (PE), after taking Wegovy Be age 75 or younger The condition required an emergency room visit or hospitalization Exclusions from a Wegovy blood clot lawsuit include that you had previous blood clot-related treatments or received current treatments for other unrelated serious health conditions
Many people microdosing GLP-1 medications are taking a compounded GLP-1, which means the drug was made in a compounded pharmacy and not approved by the FDA for safety, quality or efficiency
Laboratory research record on GLP-1S [PMID: 39114239] PubMed laboratory record discussing GLP-1S in a research context
The standard approach begins at 0.25 mg once weekly, with gradual increases every four weeks until reaching the maintenance dose of 1.7 mg or 2.4 mg weekly
Instead, it varies based on the provider you choose, the dose, and whether your insurance provides any coverage
"We're not sure why, but it does tend to get better with time," Corrado says